ARCHIVES

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Cancer Meetings Listed

March 26, 1993